Drug-resistant tuberculosis in Yangon, Myanmar

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 11-12, 2005, Pages 846-851

  Phyu, Sabai ^a,d   Lwin, Thandar ^a,c   Ti, Ti ^c   Maung, Win ^c   Mar, Win W ^c   Shein, San S ^c   Grewal, Harleen M S ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c National TB Programme   (Myanmar)

^d NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONFIDENCE INTERVAL; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; HUMAN; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; MYANMAR; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SPUTUM SMEAR; TREATMENT FAILURE; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYANMAR; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 30544452323     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540500265065     Document Type: Article

References (22)

1. World Health Organization report 2002. Global Tuberculosis Control: Surveillance, Planning, Financing. Communicable Diseases. Geneva Switzerland: World Health Organization, 2002.
2. National Tuberculosis Programme, Annual Report 2001. Ministry of Health, Department of Health, Yangon, Myanmar. 2002.
3. Myanmar Central Statistical Organization. Yangon Myanmar: Ministry of Immigration and population, 2000.
4. Phyu, S Ti, T Jureen, R Hmun, T Myint, H Htun, A et al. (2003) Drug-resistant Mycobacterium tuberculosis among new tuberculosis patients, Yangon, Myanmar Emerg Infect Dis, 9, 274-6.
5. Manual for the control of Tuberculosis. National Tuberculosis Programme, Myanmar. Yangon. Department of Health, Ministry of Health, Myanmar. 1999.
6. De Kantor, IN Kim, SJ Frieden, T Laszlo, A Luelmo, F Norval, P-Y et al. (1998) Laboratory services in tuberculosis control. Culture Part III. Geneva: World Health Organization.
7. Guidelines for the Safe Transport of Infectious Substances and Diagnostic Specimens. Geneva Switzerland: World Health Organization, 1997.
8. Chart 22. In: Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC Jr, eds. Diagnostic Microbiology. 5th edn. Philadelphia USA: Lippincott; 1997. p.1322-4.
9. The WHO/IUATLD Global project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the world report, prevalence and trends. Geneva Switzerland: World Health Organization, 1997.
10. Riantawan, P Punnotok, J Chaisuksuwan R Pransujarit, V. (1998) Resistance of Mycobacterium tuberculosis to antituberculosis drugs in the central region of Thailand, 1996 Int J Tuberc Lung Dis, 2, 616-20.
11. The World Health Organization/International Union Against Tuberculosis and Lung Diseases global project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the world: Report no. 2, Prevalence and Trends. Geneva Switzerland: World Health Organization, 2000.
12. The World Health Organization/International Union Against Tuberculosis and Lung Diseases global project on anti-tuberculosis drug resistance surveillance. Anti-tuberculosis drug resistance in the world: Report no. 3. Geneva Switzerland: World Health Organization, 2004.
13. Tansuphasiri, U Pleumpanupat, W Pandii, W Rienthong, S. (2003) Drug-resistant tuberculosis among prisoners of 3 prisons in Bangkok and the vicinity J Med Assoc Thai 86, 953-63.
14. Peter, CR Schultz, E Moser, K Cox, M Freeman, R Ramirez-Zetina, M Lomeli, MR. (1998) Drug- resistant pulmonary tuberculosis in the Baja California-San Diego County border population West J Med, 169, 208-13.
15. Paramasivan, CN. (2003) Status of drug resistance in tuberculosis after the introduction of rifampicin in India J Indian Med Assoc, 101, 154-6.
16. Rajeswari, R Balasubramanian, R Bose, MS Sekar, L Rahman, F. (2002) Private pharmacies in tuberculosis control - a neglected link Int J Tuberc Lung Dis, 6, 171-3.
17. Jindani, A Dore, CJ Mitchison, DA. (2003) Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 d Am J Respir Crit Care Med, 167, 1348-54.
18. Shimao, T. (1987) Drug resistance in tuberculosis control Tubercle, 68 (Supplement), 5-18.
19. Yoshiyama, T Yanai, H Rhiengtong, D Palittapongarnpim, P Nampaisan, O Supawitkul, S et al. (2004) Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes Int J Tuberc Lung Dis, 8, 31-8.
20. Toungoussova, OS Nizovtseva, NI Mariandyshev, AO Caugant, DA Sandven, P Bjune, G. (2004) Impact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture- positive cases of tuberculosis in the Archangel Oblast, Russia, in 1999 Eur J Clin Microbiol Infect Dis, 23, 174-9.
21. Wobeser, WL Yuan, L Naus, M Corey, P Edelson, J Heywood, N Holness, DL. (2000) Expanding the epidemiological profile: Risk factors for active tuberculosis in people immigrating to Ontario CMAJ, 163, 823-8.
22. Cantwell, MF McKenna, MT McCray, E Onorato, IM. (1998) Tuberculosis and race/ethnicity in the United States: Impact of socioeconomic status Am J Respir Crit Care Med, 157, 1016-20.